127 related articles for article (PubMed ID: 6304555)
21. Concomitant decrease in [3H]imipramine binding in cat brain and platelets after chronic treatment with imipramine.
Briley M; Raisman R; Arbilla S; Casadamont M; Langer SZ
Eur J Pharmacol; 1982 Jul; 81(2):309-14. PubMed ID: 6288407
[TBL] [Abstract][Full Text] [Related]
22. Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites.
Barbaccia ML; Gandolfi O; Chuang DM; Costa E
Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5134-8. PubMed ID: 6308674
[TBL] [Abstract][Full Text] [Related]
23. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
Wamsley JK; Byerley WF; McCabe RT; McConnell EJ; Dawson TM; Grosser BI
J Clin Psychiatry; 1987 Mar; 48 Suppl():19-25. PubMed ID: 3029045
[TBL] [Abstract][Full Text] [Related]
24. 5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
Barker EL; Sanders-Bush E
Mol Pharmacol; 1993 Oct; 44(4):725-30. PubMed ID: 8232222
[TBL] [Abstract][Full Text] [Related]
25. [Mechanism of action of various psychotropic agents on serotonin receptors and the transmembrane signal control].
Mikuni M
Hokkaido Igaku Zasshi; 1987 May; 62(3):417-29. PubMed ID: 3610034
[TBL] [Abstract][Full Text] [Related]
26. 5HT2 binding sites after mianserin: comparison of loss of sites and brain levels of drug.
Sanders-Bush E; Breeding M; Roznoski M
Eur J Pharmacol; 1987 Jan; 133(2):199-204. PubMed ID: 3816985
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of beta-adrenergic receptors following repeated injections of desmethylimipramine: permissive role of serotonergic axons.
Brunello N; Barbaccia ML; Chuang DM; Costa E
Neuropharmacology; 1982 Nov; 21(11):1145-9. PubMed ID: 6294548
[TBL] [Abstract][Full Text] [Related]
28. Age-related changes in rat serotonergic and adrenergic systems and in receptor responsiveness to subchronic desipramine treatment.
Brunello N; Riva M; Rovescalli AC; Galimberti R; Racagni G
Pharmacol Toxicol; 1988 Sep; 63(3):150-5. PubMed ID: 2460847
[TBL] [Abstract][Full Text] [Related]
29. Changes in the rat brain 5-HT1A and 5-HT2 receptors after chronic administration of levoprotiline, (+)-oxaprotiline and other antidepressant drugs.
Klimek V; Zak-Knapik J; Cannizzaro C
Pol J Pharmacol Pharm; 1992; 44(6):549-60. PubMed ID: 1305956
[TBL] [Abstract][Full Text] [Related]
30. Rapid down-regulation of S2 serotonin receptors by antidepressants: noradrenergic-serotonergic interactions.
Helmeste DM
Life Sci; 1986 Jul; 39(3):223-7. PubMed ID: 3016437
[TBL] [Abstract][Full Text] [Related]
31. The effect of repeated administration of imipramine, citalopram and mianserin on responsiveness of central serotonergic, alpha 2-adrenergic and cholinergic system in mice.
Maj J; Rogóz Z; Skuza G; Sowińska H
Pol J Pharmacol Pharm; 1989; 41(4):313-9. PubMed ID: 2561380
[TBL] [Abstract][Full Text] [Related]
32. Desensitization by antidepressants of central norepinephrine receptor systems coupled to adenylate cyclase.
Sulser F; Gillespie DD; Mishra R; Manier DH
Ann N Y Acad Sci; 1984; 430():91-101. PubMed ID: 6331266
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of central serotonin S2 receptors after repeated treatment with quinupramine in rats.
Sakamoto H; Yokoyama N; Nishimoto T; Murai K; Tatsumi H; Kohno S; Ohata K
Jpn J Pharmacol; 1987 Apr; 43(4):369-77. PubMed ID: 3039217
[TBL] [Abstract][Full Text] [Related]
34. Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites.
Duncan GE; Paul IA; Powell KR; Fassberg JB; Stumpf WE; Breese GR
J Pharmacol Exp Ther; 1989 Jan; 248(1):470-7. PubMed ID: 2536433
[TBL] [Abstract][Full Text] [Related]
35. Adaptation of brain 5HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior.
Smith RL; Barrett RJ; Sanders-Bush E
J Pharmacol Exp Ther; 1990 Aug; 254(2):484-8. PubMed ID: 2166792
[TBL] [Abstract][Full Text] [Related]
36. 5-Hydroxytryptamine uptake and imipramine binding sites in neurotumor NCB-20 cells.
Nakaki T; Roth BL; Chuang DM; Costa E
J Neurochem; 1985 Sep; 45(3):920-5. PubMed ID: 3875688
[TBL] [Abstract][Full Text] [Related]
37. Neurochemical and behavioral correlates of antidepressant drug action.
Mann E; Enna SJ
Life Sci; 1982 May; 30(19):1653-61. PubMed ID: 6285102
[TBL] [Abstract][Full Text] [Related]
38. Effects of combined administration of imipramine and chlorpromazine on beta- and alpha 2-adrenergic receptors in rat cerebral cortex.
Mikuni M; Stoff DM; Meltzer HY
Eur J Pharmacol; 1983 May; 89(3-4):313-6. PubMed ID: 6307713
[TBL] [Abstract][Full Text] [Related]
39. On the mode of action of mianserin.
Leonard BE
Adv Biochem Psychopharmacol; 1982; 31():301-19. PubMed ID: 6282060
[No Abstract] [Full Text] [Related]
40. Imipramine: effect of ovarian steroids on modifications in serotonin receptor binding.
Kendall DA; Stancel GM; Enna SJ
Science; 1981 Mar; 211(4487):1183-5. PubMed ID: 6258229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
